Researchers are left with the challenge of predicting how strongly a potential drug molecule will bind to its target, so ...

Precise calculations of binding free energy are pivotal in reducing the high costs and inefficiencies of drug discovery. A recent study presents PairMap, an innovative computational tool that ...

Hitting targets embedded within the cell membrane has long been difficult for drug developers due to the membrane's challenging biochemical properties. Now, chemists have demonstrated new ...

Vijayapura: The Centre of Advanced Medical Research (CAMR), in collaboration with the school of applied science and ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing ...

At NVIDIA's GTC 2025 event in San Jose, California, this week – the so-called "Super Bowl of AI" – the chip giant announced multiple partnerships leveraging the power of AI to turbocharge applications ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug molecule and the target being crucial for reducing drug discovery costs, ...